Paul Dodd
Director/Miembro de la Junta en Merck Sharp & Dohme (Holdings) Pty Ltd. .
Perfil
Paul Dodd is currently a Director at Merck Sharp & Dohme (Holdings) Pty Ltd.
He was formerly a Director at Viralytics Pty Ltd.
Cargos activos de Paul Dodd
| Empresas | Cargo | Inicio |
|---|---|---|
Merck Sharp & Dohme (Holdings) Pty Ltd.
 Merck Sharp & Dohme (Holdings) Pty Ltd. MiscellaneousMiscellaneous Merck Sharp & Dohme (Holdings) Pty Ltd. operates as an investment holding company. The company is headquartered in Macquarie Park, Australia. | Director/Miembro de la Junta | - |
Antiguos cargos conocidos de Paul Dodd.
| Empresas | Cargo | Fin |
|---|---|---|
| VIRALYTICS LTD. | Director/Miembro de la Junta | - |
Experiencias
Funciones ocupadas
Relaciones
Relaciones de 1er grado
Empresas vinculadas al 1er grado
Hombre
Mujer
Administradores
Ejecutivos
Empresas relacionadas
| Empresas privadas | 2 |
|---|---|
Viralytics Pty Ltd.
 Viralytics Pty Ltd. BiotechnologyHealth Technology Viralytics Pty Ltd. engages in the development and commercialization of oncolytic immunotherapies that harness the power of certain viruses to infect and kill cancer cells. Its product, CAVATAK, is a genetically unmodified proprietary formulation of the common cold Coxsackievirus Type A21. The company was founded in 1984 and is headquartered in Sydney, Australia. | Health Technology |
Merck Sharp & Dohme (Holdings) Pty Ltd.
Merck Sharp & Dohme (Holdings) Pty Ltd. MiscellaneousMiscellaneous Merck Sharp & Dohme (Holdings) Pty Ltd. operates as an investment holding company. The company is headquartered in Macquarie Park, Australia. | Miscellaneous |
- Bolsa de valores
- Insiders
- Paul Dodd
